Anavex Life Sciences Corp (AVXL)
Financing Cash Flow
$113.00K
Quarterly · Period ending: · USD
AVXL Financing Cash Flow
Latest reported$113.00Kperiod ending
Latest reported$113.00Kperiod ending
AVXL Quarterly Cash from Financing ($0.00 → $113.00K)
Quarterly financing cash flow
High-resolution chart · PNG
AVXL financing cash flow history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 113,000 | |
| 113,000 | |
| 36,323,000 | |
| 10,017,000 | |
| -2,143,000 | |
| 852,000 | |
| 708,000 | |
| 89,000 | |
| 4,550,000 | |
| 7,277,000 | |
| 59,000 | |
| 2,056,326 | |
| 9,003,000 | |
| 18,334,000 | |
| 258,000 | |
| 2,444 | |
| 6,910,286 | |
| 11,835,685 | |
| 2,539,565 | |
| 2,222,208 | |
| 89,221,649 | |
| 35,818,585 | |
| 25,979,959 | |
| 7,884,645 | |
| 5,100,297 | |
| 4,367,540 | |
| 10,997,952 | |
| 3,470,730 | |
| 9,292,545 | |
| 3,074,134 | |
| 1,944,700 | |
| 1,156,218 | |
| 2,259,142 | |
| 428,907 | |
| 4,228,520 | |
| 4,838,716 | |
| 4,415,837 | |
| 2,887,849 | |
| 15,128,272 | |
| 1,323,041 | |
| 0 | |
| 0 | |
| 1,809,621 | |
| 8,763,004 | |
| 3,080,984 | |
| 0 | |
| 411,856 | |
| 0 | |
| -53,872 | |
| 9,445,160 | |
| 188,170 | |
| 827,937 | |
| 33,348 | |
| 50,000 | |
| 200,000 | |
| 245,100 | |
| 78,250 | |
| 283,750 | |
| 962,500 | |
| -165,363 | |
| 2,425,000 | |
| 168,800 | |
| 1,243,075 | |
| 473,126 | |
| 2,412,977 | |
| 1,174,470 | |
| 450,000 | |
| 580,998 | |
| 1,845,234 | |
| 451,718 | |
| 262,581 | |
| 660,415 | |
| 621,052 | |
| 475,000 | |
| 725,000 | |
| 60,000 | |
| 188,000 | |
| 65,000 | |
| 0 | |
| 33,665 | |
| -7,386 | |
| 17,447 | |
| 0 | |
| 8,939 | |
| 0 | |
| 25,000 | |
| 0 |